Strategies

Staged future-research agenda for transitioning LC assessment tools from developmental validation to safe clinical integration

Strategy · All strategies
Evidence · 4 claims (4 for) · 1 study (1 review), q3 · 0 of 1 report an effect size · 4 claims rest on one study

Description

The review's future research agenda lists five directions: prospective multicentre validation across heterogeneous pathology and surgeon experience levels; transparent, standardised annotation protocols to strengthen ground-truth reliability; evaluating "behavioural changes, learning curves, and patient outcomes, rather than relying solely on technical classification metrics"; shared benchmark datasets for reproducible external validation; and aligning tool design with intended use, distinguishing formative feedback, monitoring, and credentialing functions. For real-time AI deployment, the authors recommend alignment with the IDEAL and DECIDE-AI staged evaluation frameworks, preserving explicit human oversight.

Design Implications

Context

Requirements

Constraints

Target Learners

Target Learning Goals

Claims

Examples

-

Key Sources

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-31
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.